Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

Enterprises adopting AI cannot afford to be slowed by database lock-in. As the vector ecosystem evolves, the winners will be ...

The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Sometimes, reading Python code just isn’t enough to see what’s really going on. You can stare at lines for hours and still miss how variables change, or why a bug keeps popping up. That’s where a ...

Once upon a time, the English language was full of stories with “blossoms,” “rivers,” and “moss.” But these words are disappearing from our vocabularies — and along with them, our connection to the ...

One person that helped bring the chill was an analyst cutting his price target. Another two were executives at the biotech selling chunks of stock. 10 stocks we like better than Recursion ...

Debate over the song of the summer rages on, but if there were a contest for a word of the summer, one front-runner would surely be the onomatopoeic clanker. In recent weeks, clanker has risen to ...

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. 10 stocks we like better than ...